Articles
134
All (134)
SCI-E, SSCI, AHCI (128)
SCI-E, SSCI, AHCI, ESCI (133)
ESCI (5)
Scopus (131)
TRDizin (17)
29. First Allogeneic Hematopoietic Stem Cell Transplantation in RASGRP1 Deficieny
BONE MARROW TRANSPLANTATION
, vol.55, pp.653-654, 2020 (SCI-Expanded, Scopus)
34. Infant Acute Lymphoblastic Leukemia with Atypical Presentation
YAMAN BAJİN H. İ., YILDIZ Y., akın ş., AYTAÇ EYÜPOĞLU Ş. S., ÜNAL CANGÜL Ş., KUŞKONMAZ B. B., et al.
Acta Medica
, vol.50, no.4, pp.57-59, 2019 (TRDizin)
50. Evaluation of drugs used in paediatric bone marrow transplantation unit in terms of drug interactions
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, vol.40, no.1, pp.274, 2018 (SCI-Expanded, Scopus)
51. Clinical pharmacist's contribution on managing drug related problems in paediatric hematopoietic stem cell transplantation
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, vol.40, no.1, pp.274-275, 2018 (SCI-Expanded, Scopus)
55. Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded, Scopus)
63. Thrombosis Associated with Childhood Solid Tumors: A Single Center Experience
PEDIATRIC BLOOD & CANCER
, vol.63, 2016 (SCI-Expanded, Scopus)
70. Multiple Bone Cysts in Patient with Congenital Afibrinogenaemia
HAEMOPHILIA
, vol.22, pp.87-88, 2016 (SCI-Expanded, Scopus)
71. Hyperthyroidism After Allogeneic Hematopoietic Stem Cell Transplantation: A Report of Four Cases
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY
, vol.7, no.4, pp.349-354, 2015 (SCI-Expanded, Scopus, TRDizin)
72. OSTEOPOROSIS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED ON MODIFIED ST JUDE TOTAL XV THERAPY
PEDIATRIC BLOOD & CANCER
, vol.62, 2015 (SCI-Expanded, Scopus)
75. Risk of thrombosis in a cohort of pediatric acute lymphoblastic leukemia patients
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
, vol.13, pp.934, 2015 (SCI-Expanded, Scopus)
76. THE OUTCOME OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS WHO PRESENTED WITH HYPERLEUKOCYTOSIS
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded, Scopus)
77. PEDIATRIC MYELODYSPLASTIC SYNDROME: EXPERIENCE FROM A SINGLE CENTER
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded, Scopus)
78. Pediatric Myelodysplastic Syndrome: Experience from a Single Center
BLOOD
, vol.124, no.21, 2014 (SCI-Expanded, Scopus)
80. Importance of flexible broncoscopy in immunocompromised children with pulmonary infections
EUROPEAN RESPIRATORY JOURNAL
, vol.44, 2014 (SCI-Expanded, Scopus)
88. IMPROVED OUTCOME IN HIGH RISK GROUP PATIENTS WITH HIGH DOSE METHYLPREDNISOLONE DURING INDUCTION OF MODIFIED ST JUDE TOTAL XIIIA
PEDIATRIC BLOOD & CANCER
, vol.60, pp.70, 2013 (SCI-Expanded, Scopus)
91. RECURRENT PEDIATRIC THROMBOSIS: INFLUENCE AND UNDERLYING OR COEXISTING FACTORS
HAEMATOLOGICA
, vol.97, pp.192, 2012 (SCI-Expanded, Scopus)
92. Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
, vol.23, no.5, pp.434-9, 2012 (SCI-Expanded, Scopus)
111. Two new cases with Pearson syndrome and review of Hacettepe experience.
The Turkish journal of pediatrics
, vol.50, no.6, pp.572-6, 2008 (SCI-Expanded, Scopus)
113. Congenital coagulation factor deficiencies: Hacettepe experience
HAEMOPHILIA
, vol.14, pp.12-13, 2008 (SCI-Expanded, Scopus)
121. Varicella zoster-associated severe aplastic anemia in a child and its successful treatment with peripheral blood stem cell transplantation from HLA-5/6-identical donor.
Medical science monitor : international medical journal of experimental and clinical research
, vol.13, no.10, 2007 (SCI-Expanded, Scopus)
122. Carotid artery intima-media thickness (IMT), ambulatory blood pressure measurement (ABPM) and renal damage in thalassemia major (TM)
PEDIATRIC NEPHROLOGY
, vol.22, no.9, pp.1463, 2007 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
33
4. Succesful bone marrow transplantation from HLA 9/10 matched relative after myeloablative conditioning in a patient with PRKDC defect
ESID, Brüksel, Belgium, 18 - 21 September 2019, (Summary Text)
5. Hematopoetik Kök Hücre Nakli Yapılan Çocuk Hastalarda Erken Dönem Üriner Sistem Komplikasyonları
10. Çocuk Nefrolojisi Kongresi, Turkey, 1 - 04 May 2019, (Summary Text)
6. Hematopoetik Kök Hücre Nakli Yapılan Çocuk Hastalarda Geç Dönem Renal Komplikasyonların Ve RiskFaktörlerinin Analizi
10. Çocuk Nefrolojisi Kongresi, Turkey, 1 - 04 May 2019, (Summary Text)
7. Çocuklarda Hematopoietik Kök Hücre Nakli Sonrası Prognozun Belirlenmesinde Modifiye EBMT Skorlamasının Kullanımı
10. THD Ulusal Kemik İliği Transplantasyonu ve Hücresel, Turkey, 1 - 03 March 2018, (Full Text)
8. Çocuklarda Hematopoetik Kök Hücre Nakli Sonrası Prognozu Belirlemede Modifiye Ebmt Risk Skorlamasının Kullanımı
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 1 - 03 March 2018, (Summary Text)
9. TGF-b1 production by bone marrow mesenchymal stem cells of FANCD2 differs from other Fanconi Anemia Complemetation Groups
59th ASH Annual Meeting and Exposition (December 9-12), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)
10. Childhood leukemia in an ETV6-related Thrombocytopenia family.
YAMAN BAJİN H. İ., AYTAÇ EYÜPOĞLU Ş. S., KUŞKONMAZ B. B., ÜNAL CANGÜL Ş., OKUR F. V., ÇETİNKAYA F. D., et al.
49th Congress of the International Society of Pediatric Oncology (SIOP), Washington, Kiribati, 12 - 15 October 2017, vol.64, pp.192, (Summary Text)
11. Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience
YAMAN BAJİN H. İ., AYTAÇ EYÜPOĞLU Ş. S., KUŞKONMAZ B. B., ÜNAL CANGÜL Ş., OKUR F. V., ÇETİNKAYA F. D., et al.
49th Congress of the International Society of Paediatric Oncology (SIOP) Washington, DC, USA October 12–15, 2017, Washington, Kiribati, 12 - 15 October 2017, vol.64, pp.202, (Summary Text)
12. Clinical Pharmacists’ Contribution On Managing Drug Related Problems In Paediatric Hematopoietic Stem Cell Transplantation
46th ESCP Symposium On Clinical Pharmacy, 9 - 11 October 2017, (Summary Text)
13. PKNOX2 regulated by TGFbeta is a new candidate to explain bone marrow failure in Fanconi Anemia.
Cagnan I., Aerts Kaya F. S. F., Coşgun E., Konu Karakayalı Ö., Kuşkonmaz B. B., Çetinkaya F. D., et al.
ISEH annual meeting 2017, Frankfurt, Germany, 24 - 27 August 2017, vol.53, pp.136, (Summary Text)
15. Pediatrik Kemik İliği Nakli Ünitesinde Kullanılan İlaçların İlaç Etkileşimleri Açısından Değerlendirilmesi
3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Antalya, Turkey, 9 - 12 February 2017, (Summary Text)
16. Evaluation of the long term clinical lab
BMT ES BLOOd, 3 - 06 April 2016, (Summary Text)
17. Çocuk hastalarda ikinci allojenik hematopoetik kök hücre nakli sonuçları
9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, 03 March 2016, (Summary Text)
18. Pediatrik hematopoietik kök hücre nakli sonrasında görülen dirençli sitopenilerin rituksimab ile tedavi sonuçları
9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, 03 March 2016, (Summary Text)
19. Hematopoietic stem cell transplantation in patients with genetic hemophagocytic lymphohistiocytosis
41 st Annual Meeting of the European Society for Blood and Marrow Transplantation, 22-25 March 2015, İstanbul, Turkey, 22 - 25 March 2015, (Summary Text)
20. Hematopoietic stem cell transplantation in patient with genetic hemophagocytic lymphohistiocytosis
41st EBMTANNual Meeting,İstanbul, Turkey, 22 - 25 March 2015, (Summary Text)
21. PLATELET DERIVED GROWTH-BB INHIBITS PROLIFERATION OF HUMAN BONE MARROW DERIVED MULTIPOTENT MESENCHYMAL STEM CELLS IN PRESENCE OF FETAL CALF SERUM AND RAPIDLY SUPPRESSES PDGF-RB EXPRESSION
EHA annual meeting 2014, Milan, Italy, 12 - 15 June 2014, vol.99, pp.727, (Summary Text)
22. Fankoni Anemili Hastaların Kemik İliği Mezenkimal Kök Hücrelerinde PREP2 Gen İfadesi Donörlere Oranla Düşüş Göstermektedir.
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, (Summary Text)
23. Sağlıklı insan Mezenkimal Kök Hücre farklılaşması, çoğalması ve PDGF-R ekspresyonu üzerinde İmatinib Mesylate’ın etkisi
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, pp.51-52, (Summary Text)
24. Sağlıklı insan kemik iliği mikroçevresi ve Mezenkimal Kök Hücrelerde Platelet-Derived Growth Factor (PDGF) ve Reseptörünün (PDGF-R) incelenmesi.
1. Kök Hücre ve Hücresel Tedaviler Kongresi 2014, Kocaeli, Turkey, 20 - 23 March 2014, pp.30-31, (Summary Text)
25. Sağlıklı insan kemik iliği endosteal ve santral bölgelerinde sitokin ekspresyonları ve G-CSF etkisi.
39. Ulusal Hematoloji Kongresi 2013, Turkey, 23 - 26 October 2013, pp.42-43, (Summary Text)
26. Expression of HAS-MIR-3065-3P was significantly downregulated in fanconi anemia patient bone marrow derived mesenchymal stem cells following bone marrow transplantation.
ISSCR 2013, 15 - 18 September 2013, pp.37-38, (Summary Text)
27. DIFFERENTIAL CYTOKINE EXPRESSION PROFILE OF HEALTHY HUMAN BONE MARROW PLASMA SAMPLES FROM THE ENDOSTEAL AND VASCULAR REGION
ISEH annual meeting 2013, Vienna, Austria, 22 - 25 August 2013, vol.41, pp.61, (Summary Text)
28. ASSESSMENT OF HUMAN BONE MARROW PLASMA SAMPLES SUGGESTS A DIFFERENT ROLE FOR MESENCHYMAL STROMAL CELLS IN DISTINCT AREAS MEDIATED BY PDGF-BB/PDGF-R
ISEH annual meeting 2013, Vienna, Austria, 22 - 25 August 2013, vol.41, pp.61, (Summary Text)
29. HOX-TALE genes show highly conserved yet heterogeneous expression profiles among fanconi anemia patients and healthy donors
HOX and TALE Transcription Factors in Development and Disease, Madrid, Spain, 28 November 2012 - 01 December 2010, pp.53, (Summary Text)
30. Expression of HOX genes in the bone marrow derived mesenchymal stromal/stem cells from Fanconi anemia patients changes following bone marrow transplantation.
ISSCR annual meeting 2012, 13 - 16 June 2012, vol.1, pp.126, (Summary Text)
31. İnflamatuvar barsak hastalığı ile prezente olan bir olguda interlökin-10 reseptör defekti
Allerjik Hastalıklar ve Klinik İmmünolojide Tedavi, Antalya, Turkey, 01 November 2011, (Full Text)
32. Mukolipidozis Tip Ii’ Hastalığında Kemik İliği Kökenli Mezenkimal Kök Hücrelerin Elde Edilmesi Ve Karakterizasyonu
2. Lizozomal Hastalıklar Kongresi 2010, Turkey, 29 - 30 April 2010, pp.68, (Summary Text)
33. ‘I-Cell’ hastalığında kemik iliği kökenli mezenkimal kök hücrelerin karakterizasyonu
6. Ulusal KIT ve Kök Hücre Tedavileri Kongresi 2010, Turkey, 4 - 06 March 2010, pp.141, (Summary Text)
